Previous Close | 61.74 |
Open | 61.90 |
Bid | 64.20 x 200 |
Ask | 64.40 x 200 |
Day's Range | 60.67 - 64.89 |
52 Week Range | 24.83 - 64.89 |
Volume | |
Avg. Volume | 545,367 |
Market Cap | 3.307B |
Beta (5Y Monthly) | 1.01 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
On May 1, 2024, Thomas Krummel, Director at PROCEPT BioRobotics Corp (NASDAQ:PRCT), sold 20,000 shares of the company.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript May 1, 2024 PROCEPT BioRobotics Corporation beats earnings expectations. Reported EPS is $-0.51, expectations were $-0.55. PRCT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to PROCEPT […]
PROCEPT BioRobotics ( NASDAQ:PRCT ) First Quarter 2024 Results Key Financial Results Revenue: US$44.5m (up 83% from 1Q...